butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
|
|
|
- CAS-Nr.
- 2227199-31-5
- Englisch Name:
- butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
- Synonyma:
- Tofatinib Impurity 12;Tofacitib related impurities 40;N-Butyl 3-Oxopropanoate Tofacitinib;Butyl 3-[4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanoate;ethyl 4-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-4-oxobutanoate;Butyl 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate;1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, butyl ester, (3R,4R)-;3-(3R,4R)-3-(6,7-dihydro-5H-pyrrolo[2,3d]pyrimidin-4-yl x(methyl)amino)4-methylpiperidin-1-yl)-3-oxopropionic acid]butyl ester;Butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate (Tofacitinib Impurity）
- CBNumber:
- CB23956193
- Summenformel:
- C20H29N5O3
- Molgewicht:
- 387.47596
- MOL-Datei:
- 2227199-31-5.mol
|
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Eigenschaften
- Dichte
- 1?+-.0.06 g/cm3(Predicted)
- pka
- 13.31±0.50(Predicted)
Sicherheit
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Chemische Eigenschaften,Einsatz,Produktion Methoden
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 27)Lieferanten
2227199-31-5()Verwandte Suche:
- Tofacitib related impurities 40
- Butyl 3-[4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanoate
- N-Butyl 3-Oxopropanoate Tofacitinib
- Tofatinib Impurity 12
- 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, butyl ester, (3R,4R)-
- Butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate (Tofacitinib Impurity）
- Butyl 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
- 3-(3R,4R)-3-(6,7-dihydro-5H-pyrrolo[2,3d]pyrimidin-4-yl x(methyl)amino)4-methylpiperidin-1-yl)-3-oxopropionic acid]butyl ester
- ethyl 4-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-4-oxobutanoate
- 2227199-31-5
